BDR Pharma inks licensing pact with Eli Lilly for Covid-19 treatment drug
24 May 2021

https://health.economictimes.indiatimes.com/news/pharma/bdr-pharma-inks-licensing-pact-with-eli-lilly-for-covid-19-treatment-drug/82764893

 

BDR Pharma inks licensing pact with Eli Lilly for Covid-19 treatment drug

Baricitinib has received restricted emergency use approval, for use in combination with Remdesivir, for treatment of suspected or laboratory-confirmed Covid-19 in hospitalized adults and pediatric patients of two years age or older, requiring supplemental oxygen, invasive mechanical ventilation, or extracorporeal membrane oxygenation.